Search filters

List of works by Harold J. Burstein

A dynamic portrait of adverse events for breast cancer patients: results from a phase II clinical trial of eribulin in advanced HER2-negative breast cancer

scientific article published on 06 October 2020

Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update

scientific article published on 05 December 2018

Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update

scientific article published on 19 November 2018

Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression

scientific article published on 16 February 2016

Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression Summary

scientific article published in March 2016

Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial.

scientific article published on 28 March 2016

Adjuvant endocrine therapy for postmenopausal women: Type and duration

scientific article published on 14 August 2015

Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update

scientific article

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer

scientific article

Adjuvant ovarian suppression in premenopausal breast cancer

scientific article

Adjuvant therapy in stage I carcinoma of the breast: the influence of multigene analyses and molecular phenotyping.

scientific article published on July 2012

American Society of Clinical Oncology Clinical Practice Guideline Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer ⬇️

scientific article published on August 6, 2010

American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Chemotherapy Sensitivity and Resistance Assays ⬇️

scientific article published on July 25, 2011

American Society of Clinical Oncology Technology Assessment Working Group Update: Use of Aromatase Inhibitors in the Adjuvant Setting ⬇️

scientific article published on 05 May 2003

American Society of Clinical Oncology Technology Assessment: chemotherapy sensitivity and resistance assays

scientific article published on 2 August 2004

American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer

scientific article

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer

scientific article

American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition

scientific article

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

scientific article

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002.

scientific article

Aromatase inhibitors and arthralgias: a new frontier in symptom management for breast cancer survivors

scientific article published on 01 September 2007

Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective Study

scientific article published on 24 April 2020

Blocking the Cycle: Cyclin-Dependent Kinase 4/6 Inhibitors in Metastatic, Hormone Receptor-Positive Breast Cancer

scientific article published on 3 June 2017

Breast Cancer

Breast Cancer Version 2.2015.

scientific article

Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

scientific article published on 01 April 2020

Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology

scientific article published in March 2018

Breast Cancer: Noninvasive and Special Situations

article

Breast cancer

scientific article published on 01 May 2005

Breast cancer version 3.2014.

scientific article

Breast cancer, version 3.2013: featured updates to the NCCN guidelines

scientific article published on July 2013

Breast cancer. Clinical practice guidelines in oncology

scientific article

Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival

scientific article published on 26 June 2008

Can Axillary Node Dissection Be Omitted in a Subset of Patients with Low Local and Regional Failure Rates? ⬇️

scientific article published on October 21, 2011

Cancer-related direct-to-consumer advertising: awareness, perceptions, and reported impact among patients undergoing active cancer treatment.

scientific article published on 03 August 2009

Cardiac toxicity from systemic cancer therapy: a comprehensive review.

scientific article published on September 2010

Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma

scientific article

Chemotherapy for Triple-Negative Breast Cancer: Is More Better?

scientific article

Chemotherapy for metastatic breast cancer

scientific article published on 01 April 2007

Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology

scientific article

Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab era ⬇️

scientific article published on January 23, 2013

Clinicopathological features among patients with advanced human epidermal growth factor-2-positive breast cancer with prolonged clinical benefit to first-line trastuzumab-based therapy: a retrospective cohort study

scientific article

Combination antiangiogenic therapy in advanced breast cancer: a phase 1 trial of vandetanib, a VEGFR inhibitor, and metronomic chemotherapy, with correlative platelet proteomics

scientific article

Congestive heart failure risk in patients with breast cancer treated with bevacizumab.

scientific article published on 4 January 2011

Contrary Effects of the Receptor Tyrosine Kinase Inhibitor Vandetanib on Constitutive and Flow-Stimulated Nitric Oxide Elaboration in Humans ⬇️

scientific article published on April 11, 2011

Deep Time: The Long and the Short of Adjuvant Endocrine Therapy for Breast Cancer ⬇️

scientific article published on January 23, 2012

Do patients participating in clinical trials want to know study results?

scientific article published on 01 March 2003

Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy

scientific article

Endocrine Therapy for Hormone Receptor Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline Summary

scientific article published on 24 May 2016

Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline

scientific article published on 23 May 2016

Endocrine therapy with or without inhibition of epidermal growth factor receptor and human epidermal growth factor receptor 2: a randomized, double-blind, placebo-controlled phase III trial of fulvestrant with or without lapatinib for postmenopausal

scientific article

Estimation of tamoxifen metabolite concentrations in the blood of breast cancer patients through CYP2D6 genotype activity score

scientific article

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

scientific article published on 17 November 2017

Follow-up care of breast cancer survivors

scientific article published on 01 December 2003

Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer

scientific article published on 26 August 2018

HER2 or not HER2: that is the question

scientific article published on 28 February 2005

HER2 testing in breast cancer: NCCN Task Force report and recommendations.

scientific article published on July 2006

High performance teamwork training and systems redesign in outpatient oncology ⬇️

scientific article published on January 24, 2013

Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II-III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance).

scientific article

Inadvertent use of aromatase inhibitors in patients with breast cancer with residual ovarian function: cases and lessons

scientific article published on 01 June 2006

Invasive Breast Cancer

article

Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology

article

Invasive breast cancer

scientific article

Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial)

scientific article published on 19 April 2019

Lymphopenia associated with adjuvant anthracycline/ taxane regimens

scientific article published in August 2008

Making Genuine Progress Against Metastatic Breast Cancer ⬇️

scientific article published on August 27, 2012

Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines

scientific article published on July 2012

NCCN Guidelines Insights Breast Cancer, Version 1.2016.

scientific article published in December 2015

NCCN Guidelines Insights: Breast Cancer, Version 1.2017.

scientific article published in April 2017

NCCN Guidelines Insights: Breast Cancer, Version 3.2018

scientific article published on 01 February 2019

NCCN Task Force Report: Adjuvant Therapy for Breast Cancer.

scientific article

NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry

scientific article published on September 2009

NCCN Task Force Report: breast cancer in the older woman

scientific article published on January 2008

NCCN Task Force Report: mTOR inhibition in solid tumors.

scientific article published on September 2008

NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer.

scientific article published on May 2007

Novel approaches to advanced breast cancer: bevacizumab and lapatinib

scientific article published on March 2007

Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis

scientific article published on 5 July 2005

Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study

scientific article

Overall Survival Benefit With Lapatinib in Combination With Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Final Results From the EGF104900 Study ⬇️

scientific article published on June 11, 2012

Patient advocates' role in clinical trials: perspectives from Cancer and Leukemia Group B investigators and advocates

scientific article published on 05 March 2012

Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.

scientific article

Peek Before You Treat? Is It a Fantasy or Reality? ⬇️

scientific article published on September 1, 2011

Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice

scientific article

Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis

scientific article

Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactions

scientific article published on 08 March 2007

Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer.

scientific article published on November 2006

Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer

scientific article

Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease

scientific article published on February 2008

Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot study.

scientific article

Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer

scientific article published on 21 October 2005

Quality of Non–Breast Cancer Health Maintenance Among Elderly Breast Cancer Survivors ⬇️

scientific article published on April 15, 2003

Radiation therapy for ductal carcinoma in situ: a decision analysis

scientific article

Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium

scientific article published on 24 April 2020

Refining therapy for human epidermal growth factor receptor 2-positive breast cancer: T stands for trastuzumab, tumor size, and treatment strategy

scientific article published on 2 November 2009

Self-reported practices and attitudes of US oncologists regarding off-protocol therapy

scientific article published on 24 November 2008

Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update

Serial analysis of circulating tumor cells in metastatic breast cancer receiving first-line chemotherapy

scientific article published on 08 August 2020

Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

scientific article published on 02 April 2019

Should Response to Preoperative Chemotherapy Affect Radiotherapy Recommendations After Mastectomy for Stage II Breast Cancer? ⬇️

scientific article published on November 10, 2012

Surgery of the primary tumor does not improve survival in stage IV breast cancer ⬇️

scientific article published on June 29, 2011

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

scientific article published on 04 June 2018

The Legacy of Professor Aron Goldhirsch

scientific article published on 23 March 2020

The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis

scientific article published on 01 June 2006

Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithm

scientific article published in August 2003

Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: the trastuzumab and vinorelbine or taxane study

scientific article published on 01 September 2007

Trastuzumab: qui bono?

scientific article published on 21 November 2013

Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials

scientific article

Treatment of early-stage human epidermal growth factor 2-positive cancers among medicare enrollees: age and race strongly associated with non-use of trastuzumab

scientific article published on 2 August 2016

Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy

scientific article published on 09 April 2020

Update of the oxford overview: new insight and perspectives in the era of personalized medicine

scientific article published on 01 January 2012

Use and duration of chemotherapy in patients with metastatic breast cancer according to tumor subtype and line of therapy

scientific article published in January 2014

Use of the peroxisome proliferator-activated receptor (PPAR) gamma ligand troglitazone as treatment for refractory breast cancer: a phase II study

scientific article published in June 2003

VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy

scientific article

Weighing a dose-dense option for adjuvant chemotherapy and trastuzumab in early-stage breast cancer

scientific article published on 01 March 2008

With better adjuvant therapy, does breast cancer stage still matter?

scientific article published in the British Medical Journal

Paulina is supported by:

About Paulina

Help